Published
Thanks for the notice about Strattera...my son has ADHD, and although Strattera isn't currently approved for use in Canada (where we live), my doctor had mentioned it once. He is currently taking Adderall.
MedWatch - The FDA Safety Information and Adverse Event Reporting ProgramFDA notified health care professionals about a new warning for Strattera, a
drug approved for attention deficit hyperactivity disorder (ADHD) in adults
and children. The labeling is being updated with a bolded warning about the
potential for severe liver injury following two reports (a teenager and an
adult) in patients who had been treated with Strattera for several months,
both of whom recovered. Health care professionals are encouraged to report
any unexpected adverse events associated with Strattera to Eli Lilly or to
the FDA MedWatch program.
Read the MedWatch 2004 safety summary, including a link to the FDA Talk
Paper at:
http://www.fda.gov/medwatch/SAFETY/2004/safety04.htm#Strattera
Brian, ASN, RN
3 Articles; 3,695 Posts
MedWatch - The FDA Safety Information and Adverse Event Reporting Program
FDA notified health care professionals about a new warning for Strattera, a
drug approved for attention deficit hyperactivity disorder (ADHD) in adults
and children. The labeling is being updated with a bolded warning about the
potential for severe liver injury following two reports (a teenager and an
adult) in patients who had been treated with Strattera for several months,
both of whom recovered. Health care professionals are encouraged to report
any unexpected adverse events associated with Strattera to Eli Lilly or to
the FDA MedWatch program.
Read the MedWatch 2004 safety summary, including a link to the FDA Talk
Paper at:
http://www.fda.gov/medwatch/SAFETY/2004/safety04.htm#Strattera